Published in Blood Weekly, February 19th, 2004
The two-year study was led by Robert Provenzano, MD, chief of nephrology at St. John Hospital and Medical Center in Detroit. He studied 600 patients who have kidney disease and anemia at 100 locations across the United States.
Provenzano found that the injectable drug Procrit, which has been used to treat kidney disease and anemia since the 1980s, is effective when administered as infrequently as once a month, The Detroit News reported in a January 20, 2004, story.
Doctors typically require...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.